InvestorsHub Logo

Lemmiwinks

01/18/21 5:52 PM

#319972 RE: alm2 #319969

I saw that...that scares me to the core.

sts66

01/18/21 6:44 PM

#319988 RE: alm2 #319969

Somebody posted that study here a couple days ago - I read the article they referred to, and I thought there were some serious statistical problems with the data - they claimed that 29% (or 23%?) were new infections, not just re-admissions - that's impossible, only a couple dozen people in the world have officially been infected with two different strains of COVID - if reinfection was so prevalent there would be a boatload of more deaths by now. IMO those people never fully recovered from the initial infection, and the stress of taking care of COVID patients caused their infection to flare up again - I unfortunately have experience with that occurring.

couldbebetter

01/19/21 8:32 AM

#320025 RE: alm2 #319969

alm2, Unfortunately, residual damage from those who have had COVID-19 is
something that the US government does not seem interested in. They may
believe that a vaccine is sufficient to control this. What they fail to
consider is that the vaccine will not protect everyone, the benefit may
wear off over time, and some new strains of the virus may be immune to
the vaccines. What will be needed are long term, safe therapies for
those individuals with residual health issues (mainly inflammation) from
the virus. Steroids are used but they are not a safe long term solution.
Vascepa should be looked at as a potential safe long term therapy. My
disgust with JT (and I hope I am wrong on this!) is that he appears to
do nothing BOLD with regard to increasing the visibility for Vascepa
as a potentially viable and safe treatment for COVID-19's residual
health issues for some patients. (Again, it is another example of
a great drug being laid to waste because Thero does not understand
what he has or what he needs to do with it..again, I hope I'm wrong
about this!)